Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Airway Management | 5 | 2020 | 55 | 2.780 |
Why?
|
| Prostatic Neoplasms | 11 | 2023 | 330 | 1.970 |
Why?
|
| Critical Illness | 5 | 2020 | 341 | 1.790 |
Why?
|
| Intensive Care Units | 9 | 2022 | 454 | 1.210 |
Why?
|
| Catheterization, Central Venous | 4 | 2015 | 88 | 1.180 |
Why?
|
| Critical Care | 7 | 2016 | 417 | 1.170 |
Why?
|
| Catheter-Related Infections | 3 | 2015 | 41 | 1.150 |
Why?
|
| Bacteremia | 4 | 2019 | 93 | 1.050 |
Why?
|
| Specialization | 2 | 2012 | 74 | 0.800 |
Why?
|
| Anesthesiology | 2 | 2012 | 42 | 0.800 |
Why?
|
| Communication Aids for Disabled | 1 | 2022 | 6 | 0.790 |
Why?
|
| Communication Disorders | 1 | 2022 | 16 | 0.770 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2022 | 34 | 0.770 |
Why?
|
| Intubation, Intratracheal | 4 | 2019 | 192 | 0.730 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2021 | 62 | 0.690 |
Why?
|
| Radiology, Interventional | 1 | 2019 | 29 | 0.640 |
Why?
|
| Conscious Sedation | 1 | 2019 | 53 | 0.640 |
Why?
|
| Cystectomy | 3 | 2021 | 18 | 0.540 |
Why?
|
| Prostatectomy | 3 | 2014 | 51 | 0.530 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 251 | 0.520 |
Why?
|
| Prostate-Specific Antigen | 6 | 2023 | 67 | 0.520 |
Why?
|
| Central Venous Catheters | 1 | 2015 | 17 | 0.480 |
Why?
|
| Chlorhexidine | 2 | 2015 | 17 | 0.480 |
Why?
|
| Catheters, Indwelling | 3 | 2010 | 69 | 0.470 |
Why?
|
| Humans | 45 | 2023 | 60132 | 0.460 |
Why?
|
| Cross Infection | 2 | 2019 | 154 | 0.450 |
Why?
|
| Postoperative Complications | 4 | 2021 | 1172 | 0.420 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2010 | 50 | 0.420 |
Why?
|
| Patient Care Team | 1 | 2015 | 334 | 0.400 |
Why?
|
| Mass Screening | 2 | 2008 | 662 | 0.390 |
Why?
|
| Lumbar Vertebrae | 1 | 2013 | 144 | 0.380 |
Why?
|
| Spinal Fusion | 1 | 2013 | 127 | 0.380 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 405 | 0.370 |
Why?
|
| Silver Sulfadiazine | 1 | 2010 | 3 | 0.360 |
Why?
|
| Antimetabolites | 1 | 2010 | 17 | 0.360 |
Why?
|
| Fluorouracil | 1 | 2010 | 55 | 0.350 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 30 | 0.350 |
Why?
|
| Oxygen | 3 | 2007 | 309 | 0.350 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2010 | 66 | 0.340 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2020 | 75 | 0.340 |
Why?
|
| Regression Analysis | 5 | 2015 | 486 | 0.340 |
Why?
|
| Kidney Neoplasms | 3 | 2020 | 114 | 0.330 |
Why?
|
| Hypoxia | 2 | 2012 | 109 | 0.330 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2010 | 128 | 0.310 |
Why?
|
| Male | 27 | 2023 | 27971 | 0.310 |
Why?
|
| Equipment Contamination | 1 | 2008 | 32 | 0.310 |
Why?
|
| Middle Aged | 22 | 2023 | 16535 | 0.300 |
Why?
|
| Aged, 80 and over | 15 | 2021 | 5197 | 0.300 |
Why?
|
| Urethral Obstruction | 1 | 2008 | 6 | 0.300 |
Why?
|
| Ejaculation | 1 | 2007 | 8 | 0.280 |
Why?
|
| Genital Diseases, Male | 1 | 2007 | 9 | 0.280 |
Why?
|
| Urology | 2 | 2020 | 28 | 0.280 |
Why?
|
| Embolism, Fat | 1 | 2007 | 1 | 0.280 |
Why?
|
| Surgical Wound Infection | 2 | 2017 | 110 | 0.280 |
Why?
|
| Polymethyl Methacrylate | 1 | 2007 | 14 | 0.280 |
Why?
|
| Bone Cements | 1 | 2007 | 16 | 0.280 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 302 | 0.270 |
Why?
|
| Aged | 20 | 2023 | 13581 | 0.260 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2006 | 88 | 0.250 |
Why?
|
| Lung Diseases | 1 | 2007 | 166 | 0.250 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2020 | 77 | 0.240 |
Why?
|
| Adult | 20 | 2023 | 15985 | 0.240 |
Why?
|
| Staphylococcal Infections | 2 | 2017 | 116 | 0.240 |
Why?
|
| Risk Factors | 10 | 2023 | 5082 | 0.240 |
Why?
|
| Retrospective Studies | 13 | 2021 | 6139 | 0.230 |
Why?
|
| Lymph Node Excision | 2 | 2014 | 37 | 0.220 |
Why?
|
| Treatment Outcome | 11 | 2020 | 5262 | 0.210 |
Why?
|
| Neoplasm Staging | 5 | 2014 | 460 | 0.200 |
Why?
|
| Radiotherapy Dosage | 1 | 2022 | 82 | 0.190 |
Why?
|
| Comorbidity | 3 | 2013 | 1098 | 0.190 |
Why?
|
| Logistic Models | 8 | 2017 | 1259 | 0.180 |
Why?
|
| Spinal Cord Ischemia | 1 | 2020 | 16 | 0.170 |
Why?
|
| Sarcopenia | 1 | 2020 | 21 | 0.170 |
Why?
|
| Fungemia | 1 | 2019 | 7 | 0.170 |
Why?
|
| Neoadjuvant Therapy | 1 | 2020 | 72 | 0.160 |
Why?
|
| Renal Insufficiency | 1 | 2020 | 63 | 0.160 |
Why?
|
| Drainage | 1 | 2020 | 150 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 832 | 0.160 |
Why?
|
| Aortic Aneurysm | 1 | 2020 | 84 | 0.160 |
Why?
|
| Laryngoscopy | 1 | 2019 | 61 | 0.160 |
Why?
|
| Female | 17 | 2021 | 31250 | 0.160 |
Why?
|
| Risk Assessment | 5 | 2023 | 1937 | 0.150 |
Why?
|
| Incidence | 3 | 2023 | 1265 | 0.150 |
Why?
|
| Perioperative Care | 2 | 2010 | 79 | 0.150 |
Why?
|
| Anesthesia, Conduction | 1 | 2017 | 10 | 0.140 |
Why?
|
| United States | 5 | 2019 | 7622 | 0.140 |
Why?
|
| Follow-Up Studies | 5 | 2014 | 2362 | 0.140 |
Why?
|
| Subclavian Artery | 1 | 2017 | 24 | 0.140 |
Why?
|
| Surgical Procedures, Operative | 2 | 2016 | 139 | 0.140 |
Why?
|
| Candidemia | 1 | 2017 | 10 | 0.140 |
Why?
|
| Communication | 1 | 2022 | 558 | 0.140 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2017 | 24 | 0.140 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2007 | 9 | 0.140 |
Why?
|
| Early Ambulation | 1 | 2016 | 7 | 0.140 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2017 | 30 | 0.140 |
Why?
|
| Pseudomonas Infections | 1 | 2017 | 52 | 0.140 |
Why?
|
| Spinal Cord Compression | 2 | 2007 | 28 | 0.130 |
Why?
|
| Physical Therapy Modalities | 1 | 2016 | 45 | 0.130 |
Why?
|
| Inpatients | 1 | 2019 | 300 | 0.130 |
Why?
|
| Lymph Nodes | 2 | 2014 | 215 | 0.130 |
Why?
|
| Patient Care Planning | 1 | 2016 | 84 | 0.130 |
Why?
|
| Germany | 3 | 2016 | 53 | 0.130 |
Why?
|
| Radiology | 1 | 2020 | 233 | 0.130 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 98 | 0.130 |
Why?
|
| Disease Management | 1 | 2017 | 222 | 0.120 |
Why?
|
| Hand Hygiene | 1 | 2015 | 8 | 0.120 |
Why?
|
| Staphylococcus | 1 | 2015 | 16 | 0.120 |
Why?
|
| Single-Blind Method | 2 | 2016 | 136 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 78 | 0.120 |
Why?
|
| Aortic Valve Stenosis | 1 | 2017 | 172 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 107 | 0.110 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 581 | 0.110 |
Why?
|
| Blood Component Transfusion | 1 | 2013 | 8 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2014 | 138 | 0.110 |
Why?
|
| Hospital Charges | 1 | 2013 | 23 | 0.110 |
Why?
|
| Intubation | 1 | 2012 | 11 | 0.100 |
Why?
|
| Demography | 1 | 2013 | 178 | 0.100 |
Why?
|
| Laryngoscopes | 1 | 2012 | 22 | 0.100 |
Why?
|
| Hypotension | 1 | 2012 | 47 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2007 | 678 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 183 | 0.100 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 242 | 0.090 |
Why?
|
| Robotic Surgical Procedures | 1 | 2014 | 112 | 0.090 |
Why?
|
| Prevalence | 2 | 2013 | 1300 | 0.090 |
Why?
|
| Colony Count, Microbial | 1 | 2010 | 57 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2013 | 294 | 0.090 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 27 | 0.090 |
Why?
|
| Antisepsis | 1 | 2010 | 7 | 0.090 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 83 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2010 | 36 | 0.080 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 78 | 0.080 |
Why?
|
| Length of Stay | 1 | 2013 | 781 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2013 | 483 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2023 | 1035 | 0.080 |
Why?
|
| Ohio | 1 | 2008 | 26 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2010 | 1066 | 0.080 |
Why?
|
| Catheterization, Peripheral | 1 | 2008 | 46 | 0.080 |
Why?
|
| Biomarkers, Tumor | 2 | 2008 | 465 | 0.070 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2007 | 27 | 0.070 |
Why?
|
| Hypovolemia | 1 | 2007 | 17 | 0.070 |
Why?
|
| Age Distribution | 1 | 2008 | 262 | 0.070 |
Why?
|
| Equipment Design | 1 | 2008 | 318 | 0.070 |
Why?
|
| Erectile Dysfunction | 1 | 2007 | 22 | 0.070 |
Why?
|
| Hand Strength | 1 | 2007 | 29 | 0.070 |
Why?
|
| Immobilization | 1 | 2007 | 12 | 0.070 |
Why?
|
| Neuromuscular Agents | 1 | 2007 | 18 | 0.070 |
Why?
|
| Veins | 1 | 2007 | 61 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 679 | 0.070 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2006 | 2 | 0.070 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 78 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 203 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2014 | 2479 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2008 | 558 | 0.070 |
Why?
|
| Nomograms | 1 | 2006 | 10 | 0.070 |
Why?
|
| Hypothermia | 1 | 2006 | 19 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 74 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2007 | 114 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 2 | 2020 | 248 | 0.070 |
Why?
|
| Transfusion Reaction | 1 | 2006 | 46 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2007 | 236 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 129 | 0.060 |
Why?
|
| Cervical Vertebrae | 1 | 2007 | 102 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 96 | 0.060 |
Why?
|
| Time Factors | 4 | 2021 | 3618 | 0.060 |
Why?
|
| Emergencies | 1 | 2005 | 114 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 928 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 1565 | 0.060 |
Why?
|
| Biopsy | 3 | 2014 | 376 | 0.060 |
Why?
|
| Adolescent | 3 | 2015 | 5958 | 0.060 |
Why?
|
| Pain | 1 | 2007 | 406 | 0.060 |
Why?
|
| Disease Progression | 1 | 2008 | 1054 | 0.060 |
Why?
|
| Europe | 2 | 2014 | 184 | 0.050 |
Why?
|
| Norway | 1 | 2023 | 19 | 0.050 |
Why?
|
| Obesity | 1 | 2011 | 1192 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2010 | 3131 | 0.050 |
Why?
|
| Age Factors | 1 | 2007 | 1525 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1471 | 0.050 |
Why?
|
| Survival Rate | 2 | 2015 | 793 | 0.050 |
Why?
|
| Post-Dural Puncture Headache | 1 | 2020 | 5 | 0.040 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2020 | 9 | 0.040 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2020 | 15 | 0.040 |
Why?
|
| Image-Guided Biopsy | 1 | 2020 | 37 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2020 | 33 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2020 | 49 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2020 | 84 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2008 | 2616 | 0.040 |
Why?
|
| Exercise | 1 | 2007 | 918 | 0.040 |
Why?
|
| Cisplatin | 1 | 2020 | 119 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 2020 | 100 | 0.040 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 92 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2020 | 237 | 0.040 |
Why?
|
| Blood Culture | 1 | 2017 | 12 | 0.030 |
Why?
|
| APACHE | 1 | 2017 | 51 | 0.030 |
Why?
|
| Posture | 1 | 2017 | 127 | 0.030 |
Why?
|
| Area Under Curve | 2 | 2007 | 125 | 0.030 |
Why?
|
| Austria | 1 | 2016 | 7 | 0.030 |
Why?
|
| Soft Tissue Infections | 1 | 2017 | 45 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 639 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 80 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 77 | 0.030 |
Why?
|
| Stents | 1 | 2020 | 459 | 0.030 |
Why?
|
| Hospital Mortality | 2 | 2011 | 855 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2017 | 79 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 930 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 434 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 422 | 0.030 |
Why?
|
| Mortality | 1 | 2017 | 165 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 196 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 314 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 647 | 0.030 |
Why?
|
| Kallikreins | 1 | 2014 | 9 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 75 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 70 | 0.030 |
Why?
|
| Pelvis | 1 | 2014 | 57 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 4396 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 569 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 577 | 0.030 |
Why?
|
| Patient Selection | 1 | 2014 | 453 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1002 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2010 | 53 | 0.020 |
Why?
|
| Rifampin | 1 | 2010 | 23 | 0.020 |
Why?
|
| Minocycline | 1 | 2010 | 25 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 2010 | 60 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2011 | 155 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 774 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 140 | 0.020 |
Why?
|
| Lower Body Negative Pressure | 1 | 2007 | 8 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2007 | 44 | 0.020 |
Why?
|
| Blood Volume | 1 | 2007 | 42 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2007 | 9 | 0.020 |
Why?
|
| Physical Examination | 1 | 2007 | 103 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2007 | 77 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2007 | 70 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 92 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 406 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2007 | 130 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 1315 | 0.020 |
Why?
|
| Heart Rate | 1 | 2007 | 308 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 54 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1531 | 0.020 |
Why?
|
| ROC Curve | 1 | 2006 | 260 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2007 | 323 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 299 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2010 | 1851 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2007 | 284 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2007 | 522 | 0.010 |
Why?
|
| Skin | 1 | 2007 | 356 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2007 | 527 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 2118 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 1591 | 0.010 |
Why?
|
| Child | 1 | 2010 | 4336 | 0.010 |
Why?
|